Front Line Genomics 10.20.20 The international neoantigen initiative Tumour Neoantigen Selection Alliance (TESLA) has identified key parameters for immunotherapy advancement. Read
HemOnc Today 10.12.20 Hematology/oncology institutions, practices announce faculty promotions, additions Read
Endpoints News 10.09.20 Parker Institute summoned the neoantigen pioneers to compare their prediction algorithms. And they have some suggestions for the field Read
The ASCO Post 08.25.20 The Parker Institute for Cancer Immunotherapy Appoints John Connolly, PhD, as Chief Scientific Officer Read